These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25249214)

  • 21. Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria.
    Imade GE; Sagay AS; Chaplin B; Chebu P; Musa J; Okpokwu J; Hamel DJ; Pam IC; Agbaji O; Samuels J; Meloni S; Sankale JL; Okonkwo P; Kanki P
    AIDS Res Hum Retroviruses; 2014 Feb; 30(2):127-33. PubMed ID: 24164431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
    Franzetti M; Lai A; Simonetti FR; Bozzi G; De Luca A; Micheli V; Meraviglia P; Corsi P; Bagnarelli P; Almi P; Zoncada A; Balotta C
    J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
    Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
    Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco.
    Cavalcanti AM; Brito AM; Salustiano DM; Lima KO; Silva SP; Diaz RS; Lacerda HR
    Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):450-7. PubMed ID: 22666853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda.
    Reynolds SJ; Ssempijja V; Galiwango R; Ndyanabo A; Nakigozi G; Lyagoba F; Nazziwa J; Redd A; Lamers SL; Gray R; Wawer M; Serwadda D; Quinn TC
    AIDS Res Hum Retroviruses; 2017 May; 33(5):448-451. PubMed ID: 27798967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Emergence of HIV-1 Transmitted Drug Resistance Mutations Among Antiretroviral Therapy-naive Individuals in Buleleng, Bali, Indonesia.
    Megasari NLA; Oktafiani D; Fitriana E; Khairunisa SQ; Kotaki T; Ueda S; Nasronudin N; Soetjipto S; Kameoka M
    Acta Med Indones; 2019 Jul; 51(3):197-204. PubMed ID: 31699942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.
    Cavalcanti AM; Lacerda HR; Brito AM; Pereira S; Medeiros D; Oliveira S
    Mem Inst Oswaldo Cruz; 2007 Nov; 102(7):785-92. PubMed ID: 17992369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
    Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
    PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
    Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
    PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral drug resistance in a respondent-driven sample of HIV-infected men who have sex with men in Brazil.
    Bermúdez-Aza EH; Kerr LR; Kendall C; Pinho AA; de Mello MB; Mota RS; Guimarães MD; Alencar CS; de Brito AM; Dourado IC; da Batista SM; Abreu F; de Oliveira LC; de Souza Moraes A; Benzaken AS; Merchan-Hamann E; de Freitas GM; McFarland W; Albuquerque E; Rutherford GW; Sabino E
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 3():S186-92. PubMed ID: 21857316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous Detection of Major Drug Resistance Mutations of HIV-1 Subtype B Viruses from Dried Blood Spot Specimens by Multiplex Allele-Specific Assay.
    Zhang G; Cai F; de Rivera IL; Zhou Z; Zhang J; Nkengasong J; Gao F; Yang C
    J Clin Microbiol; 2016 Jan; 54(1):220-2. PubMed ID: 26560533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS; Cardoso LP; Stefani MM
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods.
    Hunt GM; Ledwaba J; Kalimashe M; Salimo A; Cibane S; Singh B; Puren A; Dean NE; Morris L; Jordan MR
    Antivir Ther; 2019; 24(3):203-210. PubMed ID: 30741163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmitted human immunodeficiency virus-1 drug resistance in a cohort of men who have sex with men in Belo Horizonte, Brazil--1996-2012.
    Tupinambás U; Duani H; Martins AV; Aleixo AW; Greco DB
    Mem Inst Oswaldo Cruz; 2013 Jun; 108(4):470-5. PubMed ID: 23828000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.
    Bertagnolio S; Parkin NT; Jordan M; Brooks J; García-Lerma JG
    AIDS Rev; 2010; 12(4):195-208. PubMed ID: 21179184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmitted drug resistance in patients with acute/recent HIV infection in Brazil.
    Ferreira ACG; Coelho LE; Grinsztejn E; Jesus CS; Guimarães ML; Veloso VG; Grinsztejn B; Cardoso SW
    Braz J Infect Dis; 2017; 21(4):396-401. PubMed ID: 28539254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
    Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
    Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity.
    García-Lerma JG; McNulty A; Jennings C; Huang D; Heneine W; Bremer JW
    J Antimicrob Chemother; 2009 Jul; 64(1):33-6. PubMed ID: 19403653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.